Skip to main content
Equibles

BDRX · Biodexa Pharmaceuticals Plc

Track BDRX — free

Use BDRX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.85 +0.05 (+6.21%) At close · Sep 4
Rebalance outlook locked
Market Cap
$872,647
Shares
1.03M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2020 FY2019 FY2017 FY2016 FY2015
GBP — — 926K 667K 70K
GBP — — 6.67M 6.26M 1.31M
GBP 6000 323K 170K 12.51M 605K
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.

Key facts CIK 1643918 CUSIP 59564R872 13F (30d) 3 filings 3 filers Visit website